Trial Profile
Efficacy and safety of inhaled compared with subcutaneous human insulin in an intensive insulin regimen for subjects with type 1 diabetes mellitus: a six-month, outpatient, parallel comparative trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Feb 2007
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Pfizer
- 13 Feb 2007 New trial record.